Eli Lillys diabetes drug, tirzepatide, also known as Mounjaro, is expected to be approved by the FDA for weight loss in 2023
The higher doses genuinely outperform
Amarasate, an extract from hops grown in New Zealand, has been shown to double the normal response GLP-1 response to eating, with a reduction in caloric intake of almost 20% at the subsequent meal
thus, only minor changes were seen in both low-density lipoprotein (LDL) and high-density lipoprotein cholesterol, free fatty acids and triglycerides [21]
Todays platforms emphasize speed, user control, and discovery
Information provided is educational and not a substitute for medical advice